NOVEL ANTI-CANCER DRUGS FOR THE TREATMENT OF LEUKAEMIAS T CONSTITUTED BY THE CHAIN A OF RICIN AND A SPECIFIC MONOCLONAL ANTIBODY

摘要

The present invention relates to an anti-cancer drug, characterized in that it contains at least one product constituted by the chain A of recin conjugated by means of a disulfide bridge with at least one fraction of a monoclonal antibody of leukaemic anti-cell specificity, and to the processes for preparing the active ingredient of said drug.